Waldencast plc ( WALD ) NASDAQ Capital Market

Cena: 2.31 ( 2.67% )

Aktualizacja 06-24 20:25
NASDAQ Capital Market
Branża: Software - Application

Notowania:


Informacje o spółce:
Sektor: Technologia
Branża: Software - Application
Zatrudnienie: 284
Giełda: NASDAQ Capital Market
Ilość akcji w obrocie: 14%
Ilość akcji: 122 212 413
Debiut giełdowy: 2021-05-12
WWW: http://www.waldencast.com
CEO: Mr. Michel Brousset
Adres: 10 Bank Street
Siedziba: 10606 White Plains
ISIN: JE00BPG99318
Opis firmy:

Waldenciast Acquisition Corp. Produkcja pielęgnacji skóry zapewnia zaawansowane leczenie skóry. Jego produkty zostały zaprojektowane, aby zminimalizować pojawienie się przedwczesnego starzenia się skóry, uszkodzeń skóry, przebarwienia, trądziku i uszkodzenia słonecznego dostępne przede wszystkim przez dermatologów, chirurgów plastycznych, spa medycznych i innych specjalistów do pielęgnacji skóry. Jego portfolio obejmuje Obagi Medical, który zapewnia transformacyjne produkty do pielęgnacji skóry sformułowane w celu zminimalizowania oznak starzenia się skóry, zachodzenia na ciemne plamy, przekładnice, drobne linie i zmarszczki oraz w celu ochrony i poprawy odcienia i tekstury skóry; oraz Obagi kliniczne, które oferuje produkty do pielęgnacji skóry zaprojektowane w celu zapobiegania wczesnym oznakom starzenia się skóry. Firma została założona w 1988 roku i ma siedzibę w White Plains w Nowym Jorku.

Wskaźniki finansowe
Kapitalizacja (USD) 258 844 740
Aktywa: 1 013 646 000
Cena: 2.31
Wskaźnik Altman Z-Score: 1.0
Słaby (wysokie ryzyko bankructwa)
Dywidenda: 0
P/E: -5.9
Ilość akcji w obrocie: 14%
Średni wolumen: 100 380
Ilość akcji 112 054 000
Wskaźniki finansowe
Przychody TTM 240 400 000
Zobowiązania: 253 212 000
Przedział 52 tyg.: 1.98 - 4.74
Piotroski F-Score: 5
Umiarkowany (średnia jakość finansowa)
EPS: -0.4
P/E branży: 29.3
Beta: -0.53
Raport okresowy: 2025-08-18
WWW: http://www.waldencast.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. Michel Brousset Founder, Chief Executive Officer & Director 0 1973
Mr. Felipe Dutra Executive Chairman 0 1965
Mr. Manuel Manfredi Chief Financial Officer 0 0
Elisabeth Milan General Counsel 0 0
Ms. Hind Sebti Founder & Chief Growth Officer 0 1979
Wiadomości dla Waldencast plc
Tytuł Treść Źródło Aktualizacja Link
Waldencast plc (WALD) Q1 2025 Earnings Call Transcript Waldencast plc (NASDAQ:WALD ) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ET Company Participants Allison Malkin - Partner ICR, Investor Relations Michel Brousset - Founder & Chief Executive Officer Manuel Manfredi - Chief Financial Officer Conference Call Participants John Chapman - Alliance Global Partners Jonna Kim - TD Cowen Operator Good day, and welcome to the Waldencast First Quarter 2025 Earnings Call. All participants will be in listen-only mode. seekingalpha.com 2025-05-14 16:49:12 Czytaj oryginał (ang.)
Waldencast Reports Q1 2025 Financial Results Q1 Net Revenue of $65.4 million, (4.1)% decline from Q1 202476.4% Adjusted Gross Margin, an improvement of 10 basis points$4.4 million of Adjusted EBITDA globenewswire.com 2025-05-13 20:15:00 Czytaj oryginał (ang.)
Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast LONDON, May 06, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform provided the details for its First Quarter Fiscal 2025 conference call and webcast. As previously announced, the Company will issue its First Quarter Fiscal 2025 results on May 13, 2025 after the close of the U.S. market. globenewswire.com 2025-05-06 20:05:00 Czytaj oryginał (ang.)
Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream A Scientific Breakthrough in Skin Renewal: A Clinically Proven Dual-Action, Slow-Release, Overnight Skin Renewal Cream for a Resurfaced, Smoother, and More Even-Looking Complexion globenewswire.com 2025-04-22 12:30:00 Czytaj oryginał (ang.)
Waldencast plc (WALD) Q4 2024 Earnings Call Transcript Waldencast plc (NASDAQ:WALD ) Q4 2024 Earnings Conference Call March 19, 2025 8:30 AM ET Company Participants Allison Malkin - Investor Relations Michel Brousset - Founder and Chief Executive Officer Manuel Manfredi - Chief Financial Officer Conference Call Participants Jonna Kim - TD Cowen Ashley Helgans - Jefferies Linda Bolton Weiser - D.A. Davidson Olivia Tong - Raymond James Operator Greetings, welcome to the Waldencast Fourth Quarter and Fiscal Year 2024 Earnings Call. seekingalpha.com 2025-03-19 16:59:38 Czytaj oryginał (ang.)
Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results Q4 Net Revenue of $72.1 million, 29.4% Comparable Net Revenue Growth and $11.2 million of Adjusted EBITDA, doubling from Q4 2023 globenewswire.com 2025-03-18 18:15:00 Czytaj oryginał (ang.)
Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform provided the details for its Fourth Quarter and Fiscal Year 2024 conference call and webcast. As previously announced, the Company will issue its Fourth Quarter and Fiscal Year 2024 results on March 18, 2025 after the close of the U.S. market. globenewswire.com 2025-03-11 18:05:00 Czytaj oryginał (ang.)
Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection New Skincare Solutions to Target Skin Brightening, Oxidative Stress, and Hydration for a Healthier, More Radiant Complexion New Skincare Solutions to Target Skin Brightening, Oxidative Stress, and Hydration for a Healthier, More Radiant Complexion globenewswire.com 2025-02-10 11:00:00 Czytaj oryginał (ang.)
Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates LONDON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced upcoming earnings release, conference call and webcast information for the fourth quarter and full fiscal year 2024 and first, second, and third quarters of fiscal year 2025. The webcasts will be available on the Investor Relations page on the company's website at https://ir.waldencast.com/ approximately 2 weeks prior to the events. globenewswire.com 2025-01-30 18:05:00 Czytaj oryginał (ang.)
Waldencast Announces Participation in the 2025 IMCAS World Congress LONDON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced its participation in the 2025 International Master Course on Aging Science (IMCAS) World Congress, which will be held in Paris from January 30, 2025 to February 1, 2025. globenewswire.com 2025-01-29 09:00:00 Czytaj oryginał (ang.)
Milk Makeup to Launch at Ulta Beauty This Spring The New York City based award-winning clean color cosmetics brand will expand to select Ulta Beauty stores nationwide and online, marking a significant milestone since its debut in 2016 NEW YORK , Jan. 28, 2025 /PRNewswire/ -- Milk Makeup, the trailblazing clean beauty brand celebrated for its iconic, high-performance formulas, inclusive ethos and part of the Waldencast plc (NASDAQ: WALD) platform, is thrilled to announce an expansion into the nation's largest beauty retailer, Ulta Beauty. Beginning this spring, Milk Makeup's cult-favorite products, including the 13x award-winning Hydro Grip Primer and internet-breaking Cooling Water Jelly Tints will be available in 600+ Ulta Beauty stores nationwide and on Ulta.com. prnewswire.com 2025-01-28 08:45:00 Czytaj oryginał (ang.)
Waldencast Announces Participation in the ICR Conference 2025 WHITE PLAINS, N.Y., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that the Company will participate in investor meetings and host a presentation at the ICR Conference 2025 being held at The Grande Lakes Orlando in Orlando, Florida on January 13, 2025. globenewswire.com 2025-01-06 18:05:00 Czytaj oryginał (ang.)
Waldencast plc. (WALD) Q3 2024 Earnings Call Transcript Waldencast plc. (NASDAQ:WALD ) Q3 2024 Earnings Conference Call November 21, 2024 8:30 AM ET Company Participants Allison Malkin - Investor Relations, ICR Michel Brousset - Founder and Chief Executive Officer Manuel Manfredi - Chief Financial Officer Conference Call Participants Jonna Kim - TD Cowen Dana Telsey - Telsey Advisory Group Sydney Wagner - Jefferies Susan Anderson - Canaccord Genuity Linda Bolton Weiser - D.A. seekingalpha.com 2024-11-22 21:20:27 Czytaj oryginał (ang.)
Waldencast Reports Q3 2024 Financial Results $70.2 million of Net Revenue Q3 2024+34.6% Comparable Net Revenue GrowthBoth brands accelerating from Q2 2024+45.5% Obagi Medical and +23.5% Milk Makeup vs Q3 2023Adjusted EBITDA of $11.4 million, up +134.0% vs Q3 2023 globenewswire.com 2024-11-20 19:00:00 Czytaj oryginał (ang.)
Waldencast plc Announces Third Quarter Fiscal 2024 Results Conference Call and Webcast LONDON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform provided the details for its Third Quarter Fiscal 2024 conference call and webcast. As previously announced, the Company will issue its Third Quarter Fiscal 2024 results on November 20, 2024 after the close of the U.S. market. globenewswire.com 2024-11-13 18:05:00 Czytaj oryginał (ang.)
Waldencast plc Announces Board Appointments and Annual General Meeting NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, announced today that Hind Sebti, Kelly Brookie and Roberto Thompson have been appointed to its board of Directors (the “Board”), effective September 26, 2024. These executives bring extensive professional experience further enhancing the breadth of talent and expertise possessed by the Board. Ms. Brookie will replace Sarah Brown who has informed the Board of her intention to not renew her mandate ahead of the Company's Annual General Meeting. The Company also announced that its Annual General Meeting is scheduled for October 28, 2024 during which the Company's shareholders will be asked to vote on the renewal of Class I and Class II directors. Following this announcement, the Board will include 11 members, each of whom possesses significant expertise, particularly in the beauty, financial and consumer products sectors. globenewswire.com 2024-10-07 21:10:00 Czytaj oryginał (ang.)
Obagi Medical Announces the Launch of ELASTIDERM® Lift Up & Sculpt Facial Moisturizer and ELASTIDERM® Advanced Filler Concentrate These New Products are the Latest Innovation to Obagi's ELASTIDERM® Collection These New Products are the Latest Innovation to Obagi's ELASTIDERM® Collection globenewswire.com 2024-09-09 13:37:00 Czytaj oryginał (ang.)
Waldencast plc (WALD) Q2 2024 Earnings Call Transcript Waldencast plc. (NASDAQ:WALD ) Q2 2024 Earnings Conference Call August 28, 2024 8:30 AM ET Company Participants Allison Malkin - Investor Relations, ICR Michel Brousset - Founder & Chief Executive Officer Manuel Manfredi - Chief Financial Officer Conference Call Participants Olivia Tong - Raymond James Linda Bolton Weiser - DA Davidson Dana Telsey - Telsey Advisory Group Operator Greetings. seekingalpha.com 2024-08-28 18:30:23 Czytaj oryginał (ang.)
Why Waldencast Stock Is Skyrocketing Today Waldencast posted Q2 sales that came in far above the market's expectations. Comparable sales growth accelerated significantly on a sequential quarterly basis. fool.com 2024-08-28 16:58:40 Czytaj oryginał (ang.)
Waldencast Reports Q2 2024 Financial Results $63.3 million of Net Revenue Q2 2024 +25.7% net revenue Comparable Growth: +30.9% Obagi Medical and +20.0% Milk Makeup vs Q2 2023 Adjusted EBITDA of $6.3 million, up +64.5% vs Q2 2023 globenewswire.com 2024-08-27 21:26:00 Czytaj oryginał (ang.)
Waldencast plc Provides Second Quarter and First Half Fiscal 2024 Earnings Conference Call and Webcast Information NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, provided second quarter and first half fiscal 2024 earnings conference call and webcast information. As previously announced, the Company will report second quarter and first half fiscal 2024 earnings on August 27th, after the close of the U.S. stock market. The Company will conduct a conference call to discuss its earnings results on Wednesday, August 28, 2024 at 8:30am ET. globenewswire.com 2024-08-21 10:45:00 Czytaj oryginał (ang.)
4 Cosmetics Stocks Worth Watching Amid Industry Challenges The Zacks Cosmetics industry is grappling with elevated inflationary pressures. Coty, Inter Parfums (IPAR), Waldencast (WALD) and Olaplex (OLPX) are capitalizing on digital advancements and innovative strategies. zacks.com 2024-08-14 15:36:24 Czytaj oryginał (ang.)
Waldencast Announces Participation in the Canaccord Genuity 44th Annual Growth Conference WHITE PLAINS, N.Y., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that the Company will participate in the Canaccord Genuity 44th Annual Growth Conference being held at the InterContinental Boston Hotel in Boston, Massachusetts. globenewswire.com 2024-08-07 20:15:00 Czytaj oryginał (ang.)
Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates WHITE PLAINS, N.Y., June 27, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced upcoming earnings release, conference call and webcast dates. globenewswire.com 2024-06-27 21:15:00 Czytaj oryginał (ang.)
Waldencast Announces Participation in Upcoming Investor Conferences WHITE PLAINS, N.Y., May 30, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that the Company will participate in upcoming investor conferences. globenewswire.com 2024-05-30 10:45:00 Czytaj oryginał (ang.)
Waldencast Reports Q1 2024 Financial Results $68.3 million of Net Revenue+21.0% Comparable Net Revenue: +20.6% Obagi Skincare and +21.5% Milk MakeupAdjusted EBITDA of $11.4 million, up +12.9% vs Q1 2023 globenewswire.com 2024-05-21 10:45:00 Czytaj oryginał (ang.)
Waldencast plc Announces First Quarter Fiscal 2024 Earnings Release Date, Conference Call and Webcast NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced that it will release its first quarter fiscal 2024 earnings results before the U.S. stock market opens on Tuesday, May 21, 2024. The Company will conduct a conference call to discuss its earnings results on the same day at 8:30am ET. globenewswire.com 2024-05-13 20:15:00 Czytaj oryginał (ang.)
Waldencast Announces Participation in CreatorIQ Connect Europe NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or “the Company”), a global multi-brand beauty and wellness platform, today announced its participation in the CreatorIQ Connect Europe conference, which will be held in London on Thursday, May 2, 2024. globenewswire.com 2024-05-01 20:05:00 Czytaj oryginał (ang.)
Waldencast Reports Fiscal Year 2023 Financial Results 2023 Net Revenue of $218.1 millionGroup Combined Comparable Revenue of $212.5 million, a 15.3% increase vs 2022Group Combined Adjusted EBITDA of $24.4 million, up from ($8.8) million in 2022 globenewswire.com 2024-04-30 10:45:00 Czytaj oryginał (ang.)
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDW NEW YORK , April 21, 2024 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Waldencast plc (NASDAQ: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Waldencast securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. prnewswire.com 2024-04-21 22:30:00 Czytaj oryginał (ang.)
TOP RANKED ROSEN LAW FIRM Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDW NEW YORK , April 15, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Waldencast plc (NASDAQ: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Waldencast securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. prnewswire.com 2024-04-15 15:51:00 Czytaj oryginał (ang.)
ROSEN,A TOP RANKED LAW FIRM, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDW NEW YORK , April 5, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Waldencast plc (NASDAQ: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Waldencast securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. prnewswire.com 2024-04-05 22:45:00 Czytaj oryginał (ang.)